|
HS Code |
223460 |
As an accredited 6-Bromo-4-Chloro-7H-Pyrrolopyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-4-Chloro-7H-Pyrrolopyrimidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
6-Bromo-4-Chloro-7H-Pyrrolopyrimidine keeps showing up in conversations among research chemists, especially those who work with heterocyclic scaffolds and medicinal chemistry projects. It’s a compound with a reputation for versatility due to its unique halogen substitution, making it stand out from its relatives in pyrrolopyrimidine chemistry. The way the bromine at position 6 and chlorine at position 4 interact with the core ring changes how this molecule behaves in coupling and substitution reactions. I’ve spent long hours in academic and industry labs, and seeing how targeted modifications lead to downstream innovations, I know why chemists keep reaching for this one. There’s always a bit of excitement unpacking a reagent with so much synthesis potential.
Being able to work with a compound like this means reactions respond differently compared to more run-of-the-mill pyrrolopyrimidines. The model scientists usually look for, like 6-Bromo-4-Chloro-7H-Pyrrolo[2,3-d]pyrimidine, brings the benefit of highly selective substitutions. This isn’t just about academic curiosity, either. When you drop this core into a Suzuki coupling or a nucleophilic aromatic substitution, the distinct positions of bromine and chlorine open up new functionalization routes. I remember screening a series of pyrimidine analogs, and this one always drew attention because the pattern of substitution makes it flexible. That means better odds of a successful hit during lead optimization, and with drug discovery moving fast, every shortcut helps.
This product typically appears as an off-white to pale yellow solid. Clean and reliable handling in the lab adds a sense of security—nobody wants ambiguous results due to impurities. Scientists care about purity, and reputable products can reach levels above 98% by HPLC. The melting point, usually found between 200-240°C, further sets quality expectations. Having experience with unreliable batches or low-grade chemicals, I appreciate batches that come with thorough analytical documentation without unnecessary filler. The molecular formula, C6H3BrClN4, isn’t just a string of letters and numbers; for project teams it’s reassurance: everyone knows exactly what building block they’re working with.
Any medicinal chemist aiming to tune a kinase inhibitor or customize a base for its electronic properties has considered 6-Bromo-4-Chloro-7H-Pyrrolopyrimidine. The combination of electron-withdrawing bromine and chlorine atoms pushes these molecules into places less reactive pyrimidines refuse to go. Consider the tough task of making a biaryl intermediate for structure-activity relationship studies. The bromine helps the molecule click together in palladium-catalyzed couplings, while the chlorine preserves the option of late-stage functionalization—a clever way to hedge your bets in a screening campaign. I’ve worked on campaigns needing fast iteration, and compounds like this cut prep times and bottlenecks, helping teams move from hypothesis to data.
Researchers in both academic and pharmaceutical labs make heavy use of this molecule while working on novel kinase inhibitors, anti-viral compounds, and molecular probes. In my group, we’ve swapped out other pyrrolopyrimidines for this variant to see immediate upticks in reaction rates and yield consistency—often saving whole weeks across a campaign. It’s easy to overlook how incremental improvements like reliable access to a halogenated core lead to publications, patents, and new therapies. College students, postdocs, lab techs—they’ve all commented on the cleaner TLCs and easier product isolation. That makes for less wasted time puzzling over ambiguous results and more drive behind the next experiment.
Too often, research projects bog down using less optimized starting points. Pyrrolopyrimidines without dual halogens run into selectivity hiccups, leading to unwanted byproducts and hard-to-isolate mixtures. With the bromo and chloro group both present on the ring, 6-Bromo-4-Chloro-7H-Pyrrolopyrimidine lets the chemist control site-selectivity more precisely. Reaction conditions that normally give a scramble of products narrow down to just the outcome you want. More than once, I’ve watched this specificity clear up confusion in SAR studies (structure-activity relationships), supporting clearer mechanistic understanding. Early project mistakes from choosing a mono-halogenated analog often chew up weeks hunting down side products; choosing the right pattern at the beginning pays off.
Substituting with other popular scaffolds like 4,6-dichloro-pyrrolopyrimidine or mono-brominated versions drives home key differences. The dual-halogen approach tempers reactivity, providing a built-in handle for further modification, while more basic scaffolds rarely offer the same choice of reactivity windows. Chemists on tight budgets sometimes go for less expensive options, only to find out that saving a few dollars at the start can mean spending ten times more on failed screens or unsuccessful scale-ups. That lesson gets passed down in every serious synthesis group. Choosing a compound that brings both selectivity and synthetic flexibility—like this bromo-chloro variant—often prevents more headaches later.
Every chemist latches on to “pain points” from past projects. Few things cause more dread than struggling with an under-characterized starting material that refuses to react the way textbooks promise. With 6-Bromo-4-Chloro-7H-Pyrrolopyrimidine, I notice colleagues breathe easier. They know a reliable supply sheds uncertainty from already-stressful timelines in both discovery and process settings. When producing multi-gram scales for preclinical batches, the last thing a process chemist needs is a slow, inefficient key step. Instead, they look for compounds that speed up route scouting and boost overall yield.
Factoring in the learning curve for junior staff, the clarity gained from a well-behaved intermediate helps new chemists avoid classic errors. They see predictable coupling, learn to spot synthetic pitfalls, and gain confidence crafting analogs. My own early successes came from working with clean reagents like this, which taught me what “good chemistry” looks like in practice. Seasoned professionals notice the subtly different NMR peaks compared to mono-halogenated relatives, confirming reaction progress without unnecessary troubleshooting. In short, quality matters not only for data, but for career growth and morale.
During recent years, disrupted global logistics put added pressure on everything from rare intermediates to basic building blocks. Compounds like 6-Bromo-4-Chloro-7H-Pyrrolopyrimidine, which used to feel abundant, suddenly became frustratingly hard to obtain at reasonable prices. That drove home the importance of working with suppliers able to guarantee consistent identity, documentation, and timely shipment. I recall collaborating with teams across continents who weighed switching projects because critical pyrrolopyrimidines took months to arrive. When a supplier stands behind each batch—confirming identity by NMR, mass spec, and HPLC—they not only keep projects moving but also help build scientific trust.
Procurement managers and lab leaders now pay closer attention. Sourcing agents watch for documentation gaps or suspiciously low prices that signal a questionable origin. Transparency around analysis reports, impurity profiles, and synthetic history keeps everyone safer—especially as regulators focus more on trace impurities and contaminant risks. Labs often build redundant supply routes just to preserve project momentum. Seeing solid, trustworthy documentation behind each drum or bottle reassures not just the bench chemist but also the safety officer, quality auditor, and project manager.
Modern labs have to balance innovation with safety and environmental care. Halogenated pyrrolopyrimidines challenge that balance since halogen atoms don’t just slide quietly through waste streams—they persist and, if mishandled, may cause harm further down the line. Experienced chemists set up clear protocols for handling, storage, and waste disposal for products like 6-Bromo-4-Chloro-7H-Pyrrolopyrimidine. Proper storage—dry, cool spaces, away from incompatible materials—stems from hard-won lessons when containers failed or reactions ran out of control. Training lab techs on spill response or fume handling isn’t just a checkbox for lab audits; it’s about preserving both people and downstream environments.
Change comes slow in the chemical industry, but a steady push for greener solvents, low-waste reactions, and rigorous documentation matters. Waste streams involving these compounds go through separate collection rounds, with teams often strategizing to cut halogenated byproducts. Regulators now scrutinize waste logs more closely, partly as a response to several high-profile environmental incidents linked to halogen persistence. I’ve been in working groups tasked with reducing per-halogenated compound usage, and every step towards cleaner synthesis reduces personal and organizational risk.
Cost and access remain top stressors. Research budgets rarely stretch as far as project leaders hope, and bulk pricing from reputable suppliers sometimes ends up higher than anticipated. Labs improvise, sometimes teaming up to place larger, joint orders for better rates or leverage academic-industry partnerships. Buying pooled stocks that split out to separate teams is another strategy—one that makes economic sense and reduces waste from excess inventory. While this might sound simple, coordinating between teams takes strong communication and buy-in from all sides.
Technical challenges aren’t far behind. Poor solubility in some solvents stalls reactions; purification may turn tricky if side products track closely on TLC or HPLC. Chemists keep robust notebooks, logging which solvent and temperature combinations work for each step. Sharing lab tips—like adding a few drops of DMSO or switching to a non-polar eluent—saves hours. Internal seminars, open notebook projects, and mentorship networks sow the seeds for smoother workflows in future generations. By pooling collective wisdom, research groups squeeze more value from every expensive gram.
Pyrrolopyrimidines, especially halogenated variants like 6-Bromo-4-Chloro-7H-Pyrrolopyrimidine, remain central in the chase for better medicines, crop protectants, and molecular probes. As more research teams post success stories and patent new uses, demand is unlikely to fade soon. Academic literature keeps building out strategies for assembling ever-more-complex analogs, frequently referencing this compound as a trusted building block. I’ve seen firsthand how a thoughtful core modification ripples through downstream research. Sometimes, a single strategic atom swap can turn an ordinary compound into a lead with transformative clinical or commercial prospects.
Students working on advanced projects see tremendous learning value. They gain real-world experience with compounds whose reactivity profile reflects the latest thinking in directed synthesis. Instructors highlight not only chemical technique but also the business and ethical dimensions: how sourcing choices, waste minimization, and responsible communication with colleagues feed back into discovery’s broader impact. Skill with tools like this—mastering nuanced reactivity, handling with care, and thinking ahead to what comes after the experiment—creates the next generation of scientists who solve problems beyond the bench.
The competitive landscape in pharma and advanced materials means any edge in synthesis methodology can put teams ahead. With shrinking timelines for small-molecule projects and increasing pressure to deliver safer, more active compounds, high-caliber building blocks like 6-Bromo-4-Chloro-7H-Pyrrolopyrimidine make a tangible difference. I’ve seen project go/no-go decisions made based on whether teams can reliably source and scale key intermediates. Access to superior scaffolds saves not just time but sometimes the viability of the project itself.
People often forget the human stories behind every bottle on a lab shelf. I remember the sense of accomplishment—from a rookie to an experienced hand—after a smooth reaction, pure product on the NMR, and a clear step forward in a hard-fought project. These moments don’t show up on product spec sheets, but they shape the culture of a lab. Teams that trust in their reagents, understand their properties, and communicate openly about challenges tend to find more creative solutions. Choosing the right starting materials, like quality-controlled 6-Bromo-4-Chloro-7H-Pyrrolopyrimidine, frees up mental energy for focusing on bigger questions: structure, activity, impact, and innovation.
Connections built while debating between two analogs, troubleshooting purification, or sharing the story behind a tough crystallization reinforce the notion that chemistry isn’t a lonely endeavor. Each reagent comes with lessons passed down by generations of researchers, each experiment builds on the one before it. The right building blocks do more than drive reactions—they drive people, teams, and the field forward.